Institutional investors control 24.46% of the outstanding shares in MEIP. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Other industry. Additionally, during the quarter ended December 2014, these large investors purchased a net $13.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST MANHATTAN CO. Bought 1.1 Million shares of MEI Pharma Inc
PANAGORA ASSET MANAGEMENT, INC. Bought 649.6 Thousand shares of MEI Pharma Inc
BVF PARTNERS LP Bought 600.0 Thousand shares of MEI Pharma Inc